January 19, 2011
WASHINGTONThe Federal Trade Commission (FTC) approved a final order settling charges that Nestlé S.A. made deceptive advertising claims about the health benefits of its childrens drink BOOST Kid Essentials.
Under the terms of the settlement, Nestlé HCN agreed to stop claiming BOOST Kid Essentials will reduce the risk of colds, flu and other upper respiratory tract infections unless the claim is approved by the FDA; stop claiming BOOST will reduce childrens sick-day absences and the duration of acute diarrhea in children up to age 13 unless the claims are true and backed by at least two well-designed human clinical studies; and not make any claims about the health benefits, performance or efficacy of any probiotic or nutritionally complete drinks that it sells at retail, unless the claims are true and backed by competent and reliable scientific evidence.
Click here to view the final order.
You May Also Like
Sep 28, 2023
Innovation in stress and sleep management: Holixer™– white paperSep 22, 2023
Cognitive health growth comes out on top: A range of solutions for diverse needs continue to emerge and win – product development guideSep 25, 2023
LifeVantage proxy fight heats up as revenues coolSep 28, 2023
The ashwagandha root production process: Where tradition meets science – article part threeSep 21, 2023